FDA Approves New Dosage Strength for Buprenorphine and Naloxone Film Therapy
September 8th 2018The sublingual film therapy has been approved under a 16 mg/ 4 mg dosage strength for the maintenance treatment of opioid dependence, adding to therapy options which include both brand name and generic versions.
Read More
Single-Dose Baloxavir Marboxil Improves Influenza Recovery Rates, Safety
September 7th 2018With another randomized, controlled trial involving patients at high risk for flu complications currently underway, investigators found that baloxavir may provide an option for patients with uncomplicated influenza.
Read More
CDC Creates New Guidelines for Addressing Mild TBI, Concussions in Children
September 4th 2018More than 2 million US outpatient visits and 3 million emergency department visits from 2005-2009 were accounted to children seeking care for mild TBI. Until now, no evidence-based clinical guidelines for pediatric mild TBI existed.
Read More
Deepak L. Bhatt, MD, MPH on the New NDEP Diabetes Guiding Principles
September 3rd 2018The principles included new and updated evidence over recent years in the field of diabetes self-management, education, and support, as well as shared decision-making skills and individualized care for patients.
Read More
Older, Minority Patients More Likely to Miss Anti-VEGF Treatment for nAMD
August 31st 2018Among patients who were lost to follow-up over a year, just 7.4% attended a follow-up visit after the observed 12 months. In the total loss to follow-up patient population, they reported a mean 7.8 injection treatments and 8.5 clinic visits. In patients not lost, they reported a mean 14.3 injections and 17.1 visits.
Read More
Alcon Withdraws Surgical Glaucoma Micro-Stent After New COMPASS Post-Analysis
August 29th 2018The COMPASS-XT five-year analysis reported that patients treated with the micro-stent experienced statistically significant loss of endothelial cells compared to the patients treated with lone cataract surgery.
Read More
FDA Approves Eravacycline for Complicated Intra-Abdominal Infections
August 28th 2018Relevant cIAI diagnoses include intra-abdominal abscess, stomach perforation, peritonitis, appendicitis, and more. Eravacycline's efficacy and safety were established in non-inferiority studies comparing it to the widely-used therapies ertapenem and meropenem.
Read More
Five-Year SCOT-HEART Update Indicates CTA Screening Reduces Heart Attack Deaths
August 25th 2018The update reported significant improvements in future cardiovascular risks in patients at risk for chronic angina initially referred for CTA plus standard care, versus those only referred to standard care.
Read More
FDA Approves Ivacaftor as First Therapy for Underlying Cause of Cystic Fibrosis in Young Children
August 16th 2018The approval is based on data from an ongoing phase 3 open-label safety study of 25 children with CF who have one of 10 mutations in the CFTR gene, in which ivacaftor demonstrated a consistent safety profile.
Read More
Retina Stem Cell Therapy Restores Vision in Animal Models
August 15th 2018In an effort to reprogram retina cell regeneration, investigators activated dormant stem cells then aided other stem cells in developing into rod photoreceptor cells—the most abundant cell type in the retina which first aid the retina in sensing light.
Read More